What We’re Reading: Merger Complete; Monkeypox Vaccine Efficacy Questioned; COVID-19 Travel Advisories Change
Optum and Change Healthcare have completed their merger initiated in 2021; efficacy of the Jynneos vaccine is in question after 90 of 7339 individuals contracted monkeypox after vaccination; the CDC will no longer maintain a list of country-by-country COVID-19 travel advisories.
Optum, Change Healthcare Complete Merger
Optum and Change Healthcare completed their $13 billion merger that was initiated in 2021, UnitedHealth Group announced in a
Study Raises Questions of Monkeypox Vaccine Efficacy
A study published in
CDC Ends Foreign COVID-19 Travel Advisories
The CDC has announced it will no longer maintain a list of country-by-country COVID-19 travel advisories,
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Articles
- Promising Early Efgartigimod Response Data for Generalized Myasthenia Gravis
September 18th 2025
- Iron Dysregulation Linked to MS Progression, Review Finds
September 18th 2025
- Metabolic Issues More Common in Patients With HIV
September 18th 2025
- Barriers to Gender-Affirming Surgery Persist Despite High Satisfaction Rate
September 18th 2025